CABACabaletta Bio, Inc.
What is the market doing?
In a downtrend (−33% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 22). Price is −33% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CABA is trading
Cabaletta Bio, Inc. is −16% over the past year while the S&P 500 is +18%: 35 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −33%
vs 200-day average · a clear downtrend
- RSI (14)
- 22
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 53%
Below its 52-week high
Details›
- Last close2026-10-08
- $1.94
- 1 monthS&P 500 +1.6%
- −33%
- 1 yearS&P 500 +18%
- −16%
- 5 yearsS&P 500 +86%
- −84%
- vs 50-day average$2.70
- −28%
- 52-week high
- $4.15
- 52-week low
- $1.88
- Annualised volatility
- 108%
| Year | Return |
|---|---|
| 2026 (year to date) | −11% |
| 2025 | −3.5% |
| 2024 | −90% |
| 2023 | +145% |
| 2022 | +144% |
| 2021 | −70% |
| 2020 | −11% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 5 of 7 | +6.6% |
| Feb | 7 | 2 of 7 | −9.3% |
| Mar | 7 | 1 of 7 | −18% |
| Apr | 7 | 3 of 7 | −5.4% |
| May | 7 | 4 of 7 | +11% |
| Jun | 7 | 2 of 7 | −6.6% |
| Jul | 7 | 3 of 7 | −1.8% |
| Aug | 7 | 3 of 7 | +0.46% |
| Sep | 7 | 4 of 7 | +0.68% |
| Oct | 7 | 5 of 7 | +29% |
| Nov | 7 | 5 of 7 | +29% |
| Dec | 7 | 3 of 7 | +1.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.